Clearance of blasts from peripheral blood during induction chemotherapy using exponential decay model predicts complete remission and long-term survival in adult acute myeloid leukemia

被引:0
|
作者
Konuma, T. [1 ]
Kato, S. [1 ]
Yuji, K. [1 ]
Ohno, N. [1 ]
Uchimaru, K. [1 ]
Takahashi, S. [1 ]
Tojo, A. [1 ]
机构
[1] Univ Tokyo, Inst Med Sci, Dept Hematol Oncol, Tokyo, Japan
关键词
ACUTE LYMPHOBLASTIC-LEUKEMIA; POOR-PROGNOSIS; THERAPY; CHILDREN;
D O I
10.1111/ijlh.12302
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E59 / E62
页数:4
相关论文
共 50 条
  • [32] Persistence of peripheral blood and bone marrow blasts during remission induction in adult acute lymphoblastic leukemia confers a poor prognosis depending on treatment intensity
    Cortes, J
    Fayad, L
    O'Brien, S
    Keating, M
    Kantarjian, H
    CLINICAL CANCER RESEARCH, 1999, 5 (09) : 2491 - 2497
  • [33] The Reduction of Leukemic Blasts In Bone Marrow Aspirate on Day 6 of Remission Induction Treatment Is Predictive for Complete Remission Rate and Survival in Adult Acute Myeloid Leukemia: The Results of Multicenter, Prospective Polish Adult Leukemia Group Study.
    Holowiecki, Jerzy
    Grosicki, Sebastian
    Kyrcz-Krzemien, Slawomira
    Kuliczkowski, Kazimierz
    Kielbinski, Marek
    Skotnicki, Aleksander B.
    Piatkowska-Jakubas, Beata
    Hellmann, Andrzej
    Wierzbowska, Agnieszka
    Seweryn, Marek
    Stella-Holowiecka, Beata
    Sadus-Wojciechowska, Maria
    BLOOD, 2008, 112 (11) : 680 - 681
  • [34] Long-term survival from a phase 3 study of Filgrastim in remission induction and consolidation therapy for adults with de novo acute myeloid leukemia.
    Heil, G
    Hoelzer, D
    Sanz, MA
    Lechner, K
    Yin, JA
    Noens, L
    Szer, J
    Ganser, A
    Matcham, J
    May, J
    Renwick, J
    BLOOD, 2002, 100 (11) : 341A - 342A
  • [35] The occurrence of thrombosis during intensive chemotherapy treatment for acute myeloid leukemia patients does not impact on long-term survival
    Hellou, Tamer
    Cohen, Omri
    Avigdor, Abraham
    Amitai, Irina
    Shimoni, Avichai
    Misgav, Mudi
    Canaani, Jonathan
    ANNALS OF HEMATOLOGY, 2023, 102 (05) : 1037 - 1043
  • [36] The occurrence of thrombosis during intensive chemotherapy treatment for acute myeloid leukemia patients does not impact on long-term survival
    Tamer Hellou
    Omri Cohen
    Abraham Avigdor
    Irina Amitai
    Avichai Shimoni
    Mudi Misgav
    Jonathan Canaani
    Annals of Hematology, 2023, 102 : 1037 - 1043
  • [37] The Occurrence of Thrombosis during Intensive Chemotherapy Treatment for Acute Myeloid Leukemia Patients Does Not Impact on Long-Term Survival
    Hellou, Tamer
    Cohen, Omri
    Avigdor, Abraham
    Shimoni, Avichai
    Misgav, Mudi
    Canaani, Jonathan
    BLOOD, 2022, 140 : 3229 - 3230
  • [38] The nadir peripheral white blood cell count (WBC) following remission induction therapy in older adults with acute myeloid leukemia (AML) predicts survival.
    Han, HS
    Rybicki, LA
    Kalaycio, ME
    Brown, S
    Al-Hattab, E
    Pohlman, B
    Sobecks, R
    Sekeres, MA
    BLOOD, 2003, 102 (11) : 239B - 239B
  • [39] The Early Reduction of Leukemic Blasts in Bone Marrow on Day 6 of Induction Treatment is Predictive for Complete Remission Rate and Survival in Adult Acute Myeloid Leukemia; The Results of Multicenter, Prospective Polish Adult Leukemia Group Study
    Grosicki, Sebastian
    Holowiecki, Jerzy
    Giebel, Sebastian
    Kyrcz-Krzemien, Slawomira
    Kuliczkowski, Kazimierz
    Kielbinski, Marek
    Skotnicki, Aleksander B.
    Piatkowska-Jakubas, Beata
    Hellmann, Andrzej
    Wierzbowska, Agnieszka
    Stella-Holowiecka, Beata
    Zdziarska, Barbara
    Calbecka, Malgorzata
    AMERICAN JOURNAL OF HEMATOLOGY, 2011, 86 (05) : 437 - 439
  • [40] THE MUNSTER STUDY ON INTENSIFIED INDUCTION AND CONSOLIDATION WITHOUT MAINTENANCE CHEMOTHERAPY FOR ACUTE MYELOID-LEUKEMIA (AML) - EARLY DETERMINANTS FOR LONG-TERM REMISSION
    BUCHNER, T
    HIDDEMANN, W
    KAMANABROO, D
    KOCH, P
    SCHULTE, H
    URBANITZ, D
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 191 - 191